Iranian National Formulary
The Iranian National Formulary (INF) has more than 2,300 molecules registered at the Iran's Ministry of Health, including various strengths and dosage forms. The standards regarding pharmaceutical products in Iran are determined and modified by the Pharmacopeia Council.
Iran has adopted a full generic-based National Drug Policy (NDP), with local production of essential drugs and vaccines as one of the main goals.[1]
Top 20 drug molecules and sales in Iran
[edit]| Molecule | Sales for the first 6 month of 2010 (in Iranian Rials) | |
|---|---|---|
| 1 | INTERFERON | 423,996,630,000 |
| 2 | CEFIXIME | 397,896,015,000 |
| 3 | AMOXICILLIN | 323,624,414,264 |
| 4 | CO-AMOXICLAV | 231,047,948,600 |
| 5 | ACETAMINOPHEN | 210,953,849,492 |
| 6 | ALBUMIN | 210,632,806,000 |
| 7 | DOCETAXEL | 182,924,555,600 |
| 8 | IMIPENEM+CILASTATAIN | 181,099,640,000 |
| 9 | CLOPIDOGREL | 169,915,498,015 |
| 10 | IMMUNE GLOBULIN | 160,575,717,000 |
| 11 | ENOXAPARIN | 145,486,724,600 |
| 12 | CEFALEXIN | 142,499,418,000 |
| 13 | DEXTROSE | 141,272,434,000 |
| 14 | ATORVASTATIN | 132,514,275,600 |
| 15 | PANTOPRAZOL | 130,971,241,400 |
| 16 | SALMETEROL | 127,780,028,000 |
| 17 | SODIUM CHLORIDE | 126,043,613,100 |
| 18 | IBUPROFEN | 125,621,562,500 |
| 19 | RITUXIMAB | 118,690,006,000 |
| 20 | ERYTHROPOIETIN | 110,191,720,000 |
See also
[edit]References
[edit]- ^ "Health services and pharmaceuticals to Iran". Austrade. Archived from the original on 6 March 2007.
- ^ "Iran Pharma". iran-pharma.blogspot.com. 5 February 2010. Archived from the original on 17 August 2020.